CNBM’s Tianshan Material Reports Wider Q1 2026 Core Loss as Revenue Falls 17.48%

Bulletin Express
04/27

China National Building Material (CNBM, 03323) disclosed that its Shenzhen-listed subsidiary, Tianshan Material, recorded a sharp top-line contraction and deeper underlying loss for the three months ended 31 March 2026.

Operating revenue declined 17.48% year on year to RMB 12.33 billion, down from RMB 14.95 billion a year earlier, underscoring a softer market environment for the building-materials producer.

Net profit attributable to Tianshan Material’s shareholders remained negative at RMB 1.49 billion, virtually flat versus the prior-year period (loss of RMB 1.50 billion, adjusted), implying a marginal 0.08% improvement. However, after stripping out extraordinary items, the core loss widened to RMB 1.89 billion, 21.56% deeper than the adjusted loss of RMB 1.56 billion in the same quarter last year.

Cash generation weakened markedly: operating cash outflow increased to RMB 3.33 billion, a deterioration of 54.17% from the prior-year outflow of RMB 2.16 billion. Basic and diluted earnings per share both stood at a loss of RMB 0.2102, broadly unchanged year on year, while weighted average return on net assets slipped 0.17 percentage points to –2.00%.

The balance sheet expanded modestly, with total assets rising 2.23% since year-end 2025 to RMB 282.10 billion. Net assets attributable to shareholders edged down 1.83% to RMB 73.91 billion. The company noted that comparative figures were restated following the correction of prior-period accounting errors announced on 30 March 2026.

Tianshan Material’s full first-quarter report will be available on the Shenzhen Stock Exchange website. CNBM issued the summary voluntarily and confirmed that the Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited bear no responsibility for its contents.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10